Development and validation of a race-agnostic computable phenotype for kidney health in adult hospitalized patients
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0299332 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift PLOS ONE, 2024. Verfasst von Tezcan Ozrazgat-Baslanti und 15 weiteren Autor:innen. Beteiligte Einrichtung: University of Florida Intelligent Clinical Care Center (IC3), Gainesville, Florida, United States of America. Hauptthemen laut MEDLINE: Acute Kidney Injury, Black or African American, Glomerular Filtration Rate, Hospitalization. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, National Institutes of Health and National Center for Advancing Translational Sciences Clinical and Translational Sciences Award.
Abstract (Originalsprache)
Standard race adjustments for estimating glomerular filtration rate (GFR) and reference creatinine can yield a lower acute kidney injury (AKI) and chronic kidney disease (CKD) prevalence among African American patients than non–race adjusted estimates. We developed two race-agnostic computable phenotypes that assess kidney health among 139,152 subjects admitted to the University of Florida Health between 1/2012–8/2019 by removing the race modifier from the estimated GFR and estimated creatinine formula used by the race-adjusted algorithm ( race-agnostic algorithm 1) and by utilizing 2021 CKD-EPI refit without race formula ( race-agnostic algorithm 2 ) for calculations of the estimated GFR and estimated creatinine. We compared results using these algorithms to the race-adjusted algorithm in African American patients. Using clinical adjudication, we validated race-agnostic computable phenotypes developed for preadmission CKD and AKI presence on 300 cases. Race adjustment reclassified 2,113 (8%) to no CKD and 7,901 (29%) to a less severe CKD stage compared to race-agnostic algorithm 1 and reclassified 1,208 (5%) to no CKD and 4,606 (18%) to a less severe CKD stage compared to race-agnostic algorithm 2. Of 12,451 AKI encounters based on race-agnostic algorithm 1, race adjustment reclassified 591 to No AKI and 305 to a less severe AKI stage. Of 12,251 AKI encounters based on race-agnostic algorithm 2, race adjustment reclassified 382 to No AKI and 196 (1.6%) to a less severe AKI stage. The phenotyping algorithm based on refit without race formula performed well in identifying patients with CKD and AKI with a sensitivity of 100% (95% confidence interval [CI] 97%–100%) and 99% (95% CI 97%–100%) and a specificity of 88% (95% CI 82%–93%) and 98% (95% CI 93%–100%), respectively. Race-agnostic algorithms identified substantial proportions of additional patients with CKD and AKI compared to race-adjusted algorithm in African American patients. The phenotyping algorithm is promising in identifying patients with kidney disease and improving clinical decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Florida Intelligent Clinical Care Center (IC3), Gainesville, Florida, United States of America.
- Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
- Department of Surgery, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
- University of Florida Health Outcomes and Biomedical Informatics, University of Florida, Gainesville, Florida, United States of America.
- University of Florida Health, Gainesville, Florida, United States of America.
- Department of Health Services Research, Management and Policy, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, United States of America.
ORCID-Profile: Tyler Loftus, Azra Bihorac
Förderung
- NIDDK NIH HHS
- NCATS NIH HHS
- National Institutes of Health and National Center for Advancing Translational Sciences Clinical and Translational Sciences Award
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Ozrazgat-Baslanti, T., Ren, Y., Adiyeke, E., Islam, R., Hashemighouchani, H., Ruppert, M., Miao, S., Loftus, T., Johnson-Mann, C., Madushani, R. W. M. A., Shenkman, E. A., Hogan, W., Segal, M. S., Lipori, G., Bihorac, A., & Hobson, C. (2024). Development and validation of a race-agnostic computable phenotype for kidney health in adult hospitalized patients. PLOS ONE. https://doi.org/10.1371/journal.pone.0299332
Vancouver
Ozrazgat-Baslanti T, Ren Y, Adiyeke E, Islam R, Hashemighouchani H, Ruppert M, et al. Development and validation of a race-agnostic computable phenotype for kidney health in adult hospitalized patients. PLOS ONE. 2024. doi:10.1371/journal.pone.0299332
BibTeX
@article{OzrazgatBaslanti2024,
author = {Ozrazgat-Baslanti, Tezcan and Ren, Yuanfang and Adiyeke, Esra and Islam, Rubab and Hashemighouchani, Haleh and Ruppert, Matthew and Miao, Shunshun and Loftus, Tyler and Johnson-Mann, Crystal and Madushani, R W M A and Shenkman, Elizabeth A and Hogan, William and Segal, Mark S and Lipori, Gloria and Bihorac, Azra and Hobson, Charles},
title = {Development and validation of a race-agnostic computable phenotype for kidney health in adult hospitalized patients},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0299332}
}
EUVIMED